Senolytic therapy delays early disc degeneration in mouse model
Targeting senescent cells with dasatinib-quercetin preserves disc structure and modulates degeneration-associated pathways in a mouse model.
25 May 12:05 · News-Medical
last updated on 25 May 14:57